Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
Marvelous, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 29%, Exceeds Full-Year Plan
7844 Marvelous Inc. 【J-GAAP】
Earnings ReportMarvelous Inc. <7844> [TSE Prime] announced its financial results after the market closed on January 30th (15:30). The consolidated ordinary profit for the cumulative third quarter of the fiscal year ending March 2026 (April to December) increased 28.6% from the same period last year, reaching 2.12 billion yen. Progress toward the full-year plan of 2.00 billion yen is 106.5%, already exceeding the target and also exceeding the five-year average of 85.0%.
Based on the cumulative third-quarter performance announced by the company and the unchanged full-year plan, our calculation indicates that the consolidated ordinary profit/loss for the January to March period (4Q) is expected to turn into a loss of 0.12 billion yen (compared to a profit of 0.14 billion yen in the same period last year). However, if the fourth-quarter performance remains at the same level as the first three quarters, the full-year plan may be increased.
In the most recent three-month period, from October to December (3Q), the consolidated ordinary profit increased 36.3% from the same period last year, reaching 1.74 billion yen. The operating profit margin jumped from 12.4% in the same period last year to 17.5%.
Kabutan News
Actual Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Progress Rate vs. First Half | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Apr - Dec, 2023 | 21,760 | 1,390 | 1,746 | 1,174 | 19.4 | 58.2 | Jan 31, 2024 | J-GAAP |
| Apr - Dec, 2024 | 20,720 | 1,566 | 1,656 | 1,029 | 17.0 | 92.0 | Jan 31, 2025 | J-GAAP |
| Apr - Dec, 2025 | 29,121 | 1,776 | 2,129 | 1,548 | 25.6 | 106.5 | Jan 30, 2026 | J-GAAP |
| YoY | +40.5% | +13.4% | +28.6% | +50.4% | +50.4% |
Current Period Guidance
Second Half Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Oct - Mar, 2024 | 15,086 | 1,225 | 1,427 | 740 | 12.2 | 10 | May 9, 2025 | J-GAAP |
| Oct - Mar, 2025 Guidance | 14,719 | 1,774 | 1,620 | 1,216 | 20.1 | 12 | Oct 31, 2025 | J-GAAP |
| YoY | -2.4% | +44.8% | +13.5% | +64.3% | +64.1% |
Current Period Guidance
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Mar, 2024 | 29,493 | 2,415 | 3,002 | -517 | -8.6 | 33 | May 10, 2024 | J-GAAP |
| Mar, 2025 | 27,963 | 1,817 | 1,800 | 818 | 13.5 | 10 | May 9, 2025 | J-GAAP |
| Mar, 2026 Guidance | 35,000 | 2,000 | 2,000 | 1,400 | 23.1 | 12 | May 9, 2025 | J-GAAP |
| YoY | +25.2% | +10.1% | +11.1% | +71.1% | +70.9% |
Quarterly Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Oct - Dec, 2024 | 7,843 | 974 | 1,283 | 951 | 15.7 | 12.4 | Jan 31, 2025 | J-GAAP |
| Jan - Mar, 2025 | 7,243 | 251 | 144 | -211 | -3.5 | 3.5 | May 9, 2025 | J-GAAP |
| Apr - Jun, 2025 | 8,739 | 243 | 219 | 112 | 1.9 | 2.8 | Jul 31, 2025 | J-GAAP |
| Jul - Sep, 2025 | 11,542 | -17 | 161 | 72 | 1.2 | -0.1 | Oct 31, 2025 | J-GAAP |
| Oct - Dec, 2025 | 8,840 | 1,550 | 1,749 | 1,364 | 22.5 | 17.5 | Jan 30, 2026 | J-GAAP |
| YoY | +12.7% | +59.1% | +36.3% | +43.4% | +43.4% |
Related Articles
KISSEI PHARMA, Oct-Dec (3Q) Ordinary Profit Increases by 11%, Current Fiscal Year Dividend Revised Upward by 40 Yen
BUFFALO, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 31%, Current Fiscal Year Dividend Revised Upward by 5 Yen
AZOOM, Oct-Dec (1Q) Ordinary Profit Increases by 25%
Fuji Nihon, Ordinary Profit Forecast for the Fiscal Year Revised Upward by 9%
Orient, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 34%, Oct-Dec Ordinary Profit Increases by 3.2 times
Fundely, Apr-Dec (Cumulative 3Q) Ordinary Profit Turns to Profit, Exceeds Full-Year Plan
AVANT GROUP, First Half Ordinary Profit Increases by 8%
TDSE, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 4%, Oct-Dec Ordinary Profit Increases by 49%
TAKEBISHI, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 27%, Oct-Dec Ordinary Profit Increases by 11%
BELLUNA, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 26%, Oct-Dec Ordinary Profit Increases by 42%